Fundraising Fox

Invitris

YC W23

Munich, DE · Founded 2022 · 6 employees · 2 known investors

Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.

BiotechDeep TechHealthtechNanotechnologyDrug discoveryGermanyEuropePartly Remote

Founders & leadership· Y Combinator alumni (W23)

Invitris was founded in 2022 by Patrick Grossmann and Kilian Vogele.

PGPatrick Grossmann
Patrick GrossmanninCEO & Co-FounderPatrick Grossmann studied bioinformatics at Harvard Medical School and ETH Zurich, and holds a PhD and MBA. He co-founded Invitris to develop tools for accelerating drug development focused on combating antibiotic resistance.
KVKilian Vogele
Kilian VogeleinCTO & Co-FounderHe holds a PhD in synthetic biology from TUM and has authored five patents.

Investors · 2

Y CombinatorSan Francisco · $500K
10x FoundersreportedMünchen · $270K – $2.7M

Competitors · 1

by search overlap
Amyris6 shared keywordsAmyris develops a biomanufacturing platform that uses fermentation and microbial engineering to produce natural ingredients and rare compounds at scale for partners across industries such as specialty chemicals, food ingredients, and consumer products. Founded in 2003, the company focuses on sustainable, bio-based sourcing of molecules.

Companies competing with Invitris for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

INVITRIS - Simplifying drug development & manufacturingycombinator.com · Mar 2023Innovation and Start-up Center Biotechnology (IZB) welcomes Invitris - Innovations- und Gründerzentrum Biotechnologie IZBizb-online.de · Feb 2023moma future: Viren gegen Bakterien - ZDFheutezdf.de · Feb 2023Bacteriophages the Modern Way | Science | AAASscience.org · Aug 2022

Frequently asked questions

What does Invitris do?
Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.
Who founded Invitris?
Invitris was founded by Patrick Grossmann, Kilian Vogele in 2022.
Who are Invitris's investors?
Invitris's investors include Y Combinator, 10x Founders.
Where is Invitris headquartered?
Invitris is headquartered in Munich, DE.